Saturday, October 26, 2013 Cincinnati, Ohio
Faculty

Symposium Director

Henry A. Nasrallah, MD
The Sydney W. Souers Professor and Chair
Department of Neurology and Psychiatry
St. Louis University School of Medicine
St. Louis, Missouri
Dr. Henry Nasrallah is an internationally recognized psychiatrist, educator, and researcher. He received his BS and MD degrees at the American University of Beirut (AUB). Following his psychiatric residency at the University of Rochester and neuroscience fellowship at the NIH, he served as a faculty member at the University of California, San Diego and the University of Iowa before assuming the chair of the Ohio State University Department of Psychiatry for twelve years. In 2003, following a research sabbatical, he joined the University of Cincinnati College of Medicine as Associate Dean and Professor of Psychiatry and Neuroscience .Dr. Nasrallah is currently The Sydney W. Souers Professor and Chair of the Department of Neurology and Psychiatry at the St. Louis University School of Medicine in St. Louis, Missouri.
Dr. Nasrallah was the director of the Schizophrenia Program at the University of Cincinnati, College of Medicine. His research focuses on the neurobiology and psychopharmacology of schizophrenia and related disorders. He has published more than 360 scientific articles and 400 abstracts, as well as 11 books. He is Editor-In-Chief of two prominent journals (Current Psychiatry and Schizophrenia Research) and is the co-founder of the Schizophrenia International Research Society (SIRS). He has been board-certified in both adult and geriatric psychiatry. He is a Fellow of the American College of Neuropsychopharmacology (ACNP), fellow of the American College of Psychiatrists, distinguished life fellow of the American Psychiatric Association and past President of the Cincinnati Psychiatric Society and the American Academy of Clinical Psychiatrists, and is currently the president of the Ohio Psychiatric Physicians Education and Research Foundation, and President of the University of Cincinnati College of Medicine Faculty Forum (which represents 1500 faculty members). He has twice received the NAMI Exemplary Psychiatrist Award and was recognized as the U.S. Teacher of the Year by Psychiatric Times. He has received more than 80 federal, industry, and foundation research grants and is listed in several editions of Best Doctors in America.

2013 Faculty

James W. Jefferson, MD
Director, Healthcare Technology Systems, Inc.
Distinguished Senior Scientist,
Madison Institute of Medicine®, Inc.
Clinical Professor of Psychiatry
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin
Dr. Jefferson is a clinical professor of Psychiatry at the University of Wisconsin School of Medicine and Public Health and Co-Founder and Director of the Lithium Information Center, Bipolar Disorders Treatment Information Center and Obsessive Compulsive Information Center and Director of Healthcare Technology Systems. His major clinical and research interests are in mood and anxiety disorders, psychopharmacology and the medical/psychiatry interface. He received his MD from the University of Wisconsin, and is board certified in both Psychiatry and Internal Medicine.
Roger S. McIntyre, MD
Professor of Psychiatry and Pharmacology
University of Toronto
Head of the Mood Disorders Psychopharmacology Unit
University Health Network
Toronto, Ontario
Dr. McIntyre is professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network in Toronto. Involved in multiple research endeavors which primarily aim to characterize the association between mood disorders and medical comorbidity, his research involves elucidating metabolic adverse events associated with the use of psychotropic medications, the impact of medical comorbidity on the course of mood disorders, and the effect of glucose homeostasis on neurocognition. Dr. McIntyre completed his medical degree at Dalhousie University, and received his Psychiatry residency training and Fellowship in Psychiatric Pharmacology at the University of Toronto in Canada.
Robert K. McNamara, PhD
Associate Professor of Psychiatry
University of Cincinnati College of Medicine
Cincinnati, Ohio
Dr. McNamara is associate professor of Psychiatry at the University of Cincinnati College of Medicine. His lab investigates the role of omega-3 fatty acid deficiency in the pathoetiology of recurrent neuropsychiatric disorders using animal models, postmortem brain tissue, and preclinical and clinical neuroimaging techniques. Dr. McNamara received his doctorate from the University of Victoria and Post-Doctoral Training at Northwestern University and University of Florida.
Anne Marie O'Melia, MS, MD, FAAP
Assistant Professor
University of Cincinnati Departments of Psychiatry and Pediatrics
Medical Director
Harold C. Schott Foundation Eating Disorders Program
Cincinnati, Ohio
Dr. O'Melia is an assistant professor in the Departments of Psychiatry and Pediatrics at University of Cincinnati. She is also the Medical Director of Harold C. Schott Foundation Eating Disorders Program at Lindner Center of HOPE. She has extensive experience in both primary medical and primary psychiatric settings treating eating disordered patients with a wide range of conditions including those with malnutrition, refeeding syndrome, obesity, Anorexia Nervosa, Bulimia Nervosa, Eating Disorder NOS and many comorbid psychiatric and medical conditions.
Michael E. Thase, MD
Professor of Psychiatry
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
Dr. Thase is a professor of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania. His research focuses on the assessment and treatment of mood disorders, including studies of the differential therapeutics of both depression and bipolar affective disorder. A graduate of the Ohio State University College of Medicine, Dr. Thase is a Distinguished Fellow of the American Psychiatric Association, a Founding Fellow of the Academy of Cognitive Therapy, a member of the Board of Directors of the American Society of Clinical Psychopharmacology, and Vice Chairman of the Scientific Advisory Board of the National Depression and Bipolar Support Alliance.
Peter J. Weiden, MD
Professor of Psychiatry
Director of the Psychotic Disorders Program
University of Illinois Medical Center
Chicago, Illinois
Dr. Weiden is professor of Psychiatry and Director of the Psychotic Disorders Program at the Center for Cognitive Medicine at University of Illinois Medical Center. His current research interests focus on pharmacologic and psychotherapeutic approaches to better address medication adherence problems for persons with schizophrenia. Dr. Weiden received his undergraduate degree at Swarthmore College and his medical degree at SUNY Stony Brook. Dr. Weiden completed his psychiatric residency at Payne Whitney Clinic-New York Hospital in 1985 and a psychiatric epidemiology fellowship at Mailman School of Public Health at Columbia University in 1999.